Polypharmacy in spinal cord injury: Matched cohort analysis comparing drug classes, medical complications, and healthcare utilization metrics with 24-month follow-up
Authors:
- 22 July 2024
- journal article
- research article
- Published by Taylor & Francis in The Journal of Spinal Cord Medicine
- Vol. 48 (5) , 891-900
Abstract
Polypharmacy in spinal cord injury (SCI) is common and predisposes patients to increased risk of adverse events. Evaluation of long-term health consequences and economic burden of polypharmacy in patients with SCI is explored. Retrospective cohort. The IBM Marketscan Research Databases claims-based dataset was queried to search for adult patients with SCI with a 2-year follow-up. Two matched cohorts were analyzed: those with and without polypharmacy, analyzing index hospitalization, readmissions, payments, and health outcomes. A total of 11 569 individuals with SCI were included, of which 7235 (63%) were in the polypharmacy group who took a median of 11 separate drugs over two years. Opioid analgesics were the most common medication, present in 57% of patients with SCI meeting the criteria of polypharmacy, followed by antidepressant medications (46%) and muscle relaxants (40%). Risk of pneumonia was increased for the polypharmacy group (58%) compared to the non-polypharmacy group (45%), as were urinary tract infection (79% versus 63%), wound infection (30% versus 21%), depression (76% versus 57%), and adverse drug events (24% versus 15%) at 2 years. Combined median healthcare payments were higher in polypharmacy at 2 years ($44 333 vs. $10 937, P < .0001). Majority of individuals with SCI met the criteria for polypharmacy with nearly 60% of those prescribed opioids and taking drugs from high-risk side effect profiles. Polypharmacy in SCI was associated with a greater risk of pneumonia, depression, urinary tract infections, adverse drug events, and emergency room visits over two years with four times higher overall healthcare payments at 1-year post-injury.Keywords
This publication has 53 references indexed in Scilit:
- Machine learning in clinical diagnosis, prognostication, and management of acute traumatic spinal cord injury (SCI): A systematic reviewJournal of Clinical Orthopaedics and Trauma, 2022
- Intrathecal and Oral Baclofen Use in Adults With Spinal Cord Injury: A Systematic Review of Efficacy in Spasticity Reduction, Functional Changes, Dosing, and Adverse EventsArchives of Physical Medicine and Rehabilitation, 2022
- Long-term impact of abusive head trauma in young children: Outcomes at 5 and 11 years oldJournal of Pediatric Surgery, 2021
- Exploring the perspectives on medication self-management among persons with spinal cord injury/dysfunction and providersResearch in Social and Administrative Pharmacy, 2020
- Dissociation of immunosuppressive and nociceptive effects of fentanyl, but not morphine, after repeated administration in mice: Fentanyl-induced sensitization to LPSBrain, Behavior, and Immunity, 2014
- From basics to clinical: A comprehensive review on spinal cord injuryProgress in Neurobiology, 2014
- Adverse drug events in the outpatient setting: an 11‐year national analysisPharmacoepidemiology and Drug Safety, 2010
- Potentially inappropriate medication use in elderly Japanese patientsThe American Journal of Geriatric Pharmacotherapy, 2010
- Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer PainThe Journal of Pain, 2009
- Disorders of carbohydrate and lipid metabolism in veterans with paraplegia or quadriplegia: A model of premature agingMetabolism, 1994